Abstract:
A semiconductor structure that includes at least one logic device region and at least one static random access memory (SRAM) device region wherein each device region includes a double gated field effect transistor (FET) wherein the back gate of each of the FET devices is doped to a specific level so as to improve the performance of the FET devices within the different device regions is provided. In particular, the back gate within the SRAM device region is more heavily doped than the back gate within the logic device region. In order to control short channel effects, the FET device within the logic device region includes a doped channel, while the FET device within the SRAM device region does not. A none uniform lateral doping profile with a low net doping beneath the source/drain regions and a high net doping underneath the channel would provide additional SCE control for the logic device.
Abstract:
A process for fabricating an MOS device specifically a DRAM device, featuring passivation of defects in regions of a semiconductor substrate wherein defects left unpassivated can deleteriously influence data retention time, has been developed. A high density plasma dry etching procedure used to define the DRAM conductive gate electrode can create unwanted defects in a region near the surface of uncovered portions of the semiconductor substrate during the high density plasma procedure over etch cycle. Implantation of a group V element such as arsenic can be used to passivate the unwanted plasma etch defects, thus reducing the risk of defect related device leakage phenomena. However to insure the group V implanted species remain at or near the semiconductor surface for optimum defect passivation, the group V element implantation procedure is performed after all high temperature DRAM fabrication steps, such as selective oxidation for creation of oxide spacers on the sides of the conductive gate electrode, have been completed. A slow diffusing implanted arsenic ion is the optimum candidate for passivation while faster diffusing group V elements such as phosphorous are not as attractive for defect passivation.
Abstract:
A process for fabricating an MOS device specifically a DRAM device, featuring passivation of defects in regions of a semiconductor substrate wherein defects left unpassivated can deleteriously influence data retention time, has been developed. A high density plasma dry etching procedure used to define the DRAM conductive gate electrode can create unwanted defects in a region near the surface of uncovered portions of the semiconductor substrate during the high density plasma procedure over etch cycle. Implantation of a group V element such as arsenic can be used to passivate the unwanted plasma etch defects, thus reducing the risk of defect related device leakage phenomena. However to insure the group V implanted species remain at or near the semiconductor surface for optimum defect passivation, the group V element implantation procedure is performed after all high temperature DRAM fabrication steps, such as selective oxidation for creation of oxide spacers on the sides of the conductive gate electrode, have been completed. A slow diffusing implanted arsenic ion is the optimum candidate for passivation while faster diffusing group V elements such as phosphorous are not as attractive for defect passivation.
Abstract:
Novel amidine and diamidine compounds are useful in the treatment of microbial infections, including mycobacterial, fungal and protozoal infections. Pharmaceutical formulations comprising these compounds can be used in methods of treating microbial infections.
Abstract:
To prevent unauthorized access to hardware management information in an out-of-band mode, i.e., when the operating system of the hardware is not executing, a method and apparatus employ an authentication protocol. Upon receiving a request for hardware component information in a service processor that is disposed in a hardware component, which request is received as an open session request and which request passes external to an operating system controlling the hardware component, the service processor transmits a challenge string to the requesting client application. In response to a challenge response received from the requesting client application, the service processor compares the challenge response to an expected response to the challenge. The expected challenge response is calculated by the service processor. Based on the result of the comparison, the service processor transmits an authentication response to the requesting client application indicating success or failure of the authentication process. On the client side, in response to a challenge string from the service processor, the requesting client application transmits to the service processor a challenge response, which includes an sequence number that increments with every new message from the requesting client application. The challenge response also includes a hash number calculated by the requesting client application, which hash number is a function of the challenge string, session identification number, sequence number and/or a password. Each new packet including data and/or commands from the client application includes a similarly calculated hash number.
Abstract:
The present invention relates to novel compounds and methods that are useful in treating members of the Flaviviridae family of viruses. Compounds of the present invention will have a structure according to Formulas (I)-(VI) as recited throughout the application.
Abstract:
Aqueous solutions of diterpenes such as Forskolin, its congeners, analogs and derivatives, up to approximately 6% concentration, are prepared using suitably substituted cyclodextrin as a solubilizing agents. In the absence of cyclodextrin, some diterpenes such as Forskolin are soluble in water only to concentrations of about 0.001%. Such aqueous solutions find applications in topical and systemic use, as pharmaceutical, cosmeceutical, nutraceutical preparations containing diterpenes such as Forskolin and congeners.
Abstract:
A system and method is provided for publication and discovery of the presence of nearby users on a network. When the system is enabled, the presence of the local user is published on the network. Nearby users that also have a similar system enabled can discover the local user's presence on the network. Furthermore, the local user may discovery the presence of the other nearby users that are currently publishing their presence on the network.
Abstract:
Management of links, such as URLs or other link formats, that have been embedded within blocks of data, such as data received by an E-mail application program, file transfer program, or other data transfer environment. When a block of data is received, an agent or other construct examines the block of data to identify links within the block of data. Meta-data associated with the link is extracted, and the link and associated meta-data is stored in a collective. The collective may be displayed and organized with a viewer. The viewer may be integral to an application program, such as an E-mail application program, or it may integral to an operating system, or it may be a standalone application program.
Abstract:
A method of determining a treatment plan for intensity modulated radiation treatment (IMRT) divides a three-dimensional volume of a patient into a grid of dose voxels. At least a portion of the dose voxels are designated to belong to at least one target or to at least one critical structure. An ionizing radiation dose as delivered by a plurality of beamlets each having a beamlet intensity is modeled. A non-linear convex voxel-based penalty function model is provided for optimizing a fluence map. The fluence map defines the beamlet intensities for each of the plurality of beamlets. The model is then solved based on defined clinical criteria for the target and the critical structure using an interior point algorithm with dense column handling to obtain a globally optimal fluence map.